SOPHiA GENETICS SA SOPH
Set alert
At close
Pre-market · Nov 3, 7:00 AM ET
- YTD
- +52.25%
- 1 year
- +42.20%
- Open
- 7.66
- Prev close
- 7.63
- Mkt cap
- 605.26M
- Vol
- 406.77K
- Avg vol
- 606.79K
- EPS
- -1.16
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 7.03
- High
- 7.69
- Forward P/E
- -4.09
- Beta
- 1.03
- Short ratio
- 0.89
- Inst. own
- 53.40%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 6, 2024
- 50-d avg
- 3.43
- 200-d avg
- 4.18
- 1y target
- 7.00
News
-
1 hour ago benzinga.com
Sophia Genetics Raises FY2026 Sales Guidance from $94.000M-$96.000M to $96.000M vs $95.252M Est
Sophia Genetics (NASDAQ:SOPH) raises FY2026 sales outlook from $94.000 million-$96.000 million to $96.000 million vs $95.252 million estimate.
-
1 hour ago benzinga.com
Sophia Genetics Q3 EPS $(0.24) Misses $(0.18) Estimate, Sales $24.267M Beat $24.035M Estimate
Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.18) by 33.33 percent. This is a 20 percent increase over losses of…
1 hour ago prnewswire.com
SOPHiA GENETICS Reports Third Quarter 2026 Results
BOSTON and ROLLE, Switzerland, Nov. 3, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the third quarter…
-
3 weeks ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Sophia Genetics, Maintains $14 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Sophia Genetics (NASDAQ:SOPH) with a Buy and maintains $14 price target.
-
3 weeks ago benzinga.com
SOPHiA GENETICS, Myriad Genetics Collaborate To Advance New Prostate Cancer-specific Genomic Instability Score Technology
SOPHiA GENETICS (NASDAQ:SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) today announce a collaboration to advance new prostate cancer-specific genomic instability score (PrGIS) technology to support…
-
3 months ago benzinga.com
HC Wainwright & Co. Maintains Buy on Sophia Genetics, Raises Price Target to $14
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Sophia Genetics (NASDAQ:SOPH) with a Buy and raises the price target from $12 to $14.
-
3 months ago benzinga.com
BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $9
BTIG analyst Mark Massaro maintains Sophia Genetics (NASDAQ:SOPH) with a Buy and raises the price target from $8 to $9.
-
3 months ago benzinga.com
Sophia Genetics Raises FY2026 Sales Guidance from $92.000M-$94.000M to $94.000M-$96.000M vs $93.403M Est
Sophia Genetics (NASDAQ:SOPH) raises FY2026 sales outlook from $92.000 million-$94.000 million to $94.000 million-$96.000 million vs $93.403 million estimate.
-
3 months ago benzinga.com
Sophia Genetics Q2 EPS $(0.30) Misses $(0.20) Estimate, Sales $23.310M Beat $21.729M Estimate
Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.20) by 50 percent. This is a 9.09 percent increase over losses of…
-
3 months ago benzinga.com
SOPHiA GENETICS Announces Global Collaboration To Develop, Validate, And Deploy Two Companion Diagnostics Supporting Precision Oncology Therapies With AstraZeneca
SOPHiA GENETICS (NASDAQ:SOPH) today announced a new global collaboration to develop, validate, and deploy two companion diagnostics (CDx) supporting precision oncology therapies with AstraZeneca…
3 months ago benzinga.com
This Charles Schwab Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Wall Street analysts change ratings on top stocks. See full changes on analyst ratings page. SCHW, MNST, FDUS have new outlooks.
3 months ago benzinga.com
This Urban Outfitters Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Top Wall Street analysts upgraded URBN, GPN, YETI. See what analysts think of SCHW stock.
3 months ago benzinga.com
This Crane Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Top analysts changed outlook on top names. For all changes, incl. upgrades/downgrades/initiations, see analyst ratings page. Analysts' views on CR stock.
-
3 months ago benzinga.com
HC Wainwright & Co. Initiates Coverage On Sophia Genetics with Buy Rating, Announces Price Target of $12
HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on Sophia Genetics (NASDAQ:SOPH) with a Buy rating and announces Price Target of $12.
4 months ago benzinga.com
Stock Market Today: Dow Futures Tumble, S&P 500, Nasdaq Gains As Investors Await FOMC Decision— Amkor, La-Z-Boy In Focus (UPDATED)
(Editor’s note: The future prices of benchmark tracking ETFs and the headline were updated in the story.) U.S. stock futures were mixed on Wednesday, as the Dow Jones fell, while the Nasdaq 100 and…
4 months ago benzinga.com
Sophia Genetics, Ormat Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures mostly higher, Nasdaq futures gain 100+ points. Sophia Genetics (SOPH) falls after pricing public offering of $50M. Other stocks decline in pre-market.
4 months ago benzinga.com
CarMax, Jabil And 3 Stocks To Watch Heading Into Wednesday
U.S. stock futures trading higher. CarMax, Sophia Genetics, Jabil, La-Z-Boy, and Safe Bulkers in focus. La-Z-Boy shares jump 17.7% after earnings.
-
4 months ago benzinga.com
SOPHiA GENETICS Commences Ordinary Shares Offering; Terms Undisclosed
SOPHiA GENETICS (NASDAQ:SOPH), a global leader in Ai-driven precision medicine, announced today the commencement of a proposed underwritten public offering of its ordinary shares. The Company also…
-
4 months ago benzinga.com
SOPHiA GENETICS Appoints President Ross Muken As CEO, Effective July 1, Succeeding Jurgi Camblong, Who Has Been Nominated As Board Chairman
SOPHiA GENETICS (NASDAQ:SOPH), a global leader in Ai-driven precision medicine, today confirmed, ahead of its 2026 Annual General Meeting (AGM) scheduled for June 18, 2026, the leadership changes…
-
5 months ago benzinga.com
SOPHiA GENETICS Inks MoU With Memorial Sloan Kettering Cancer Center To Form JV Between Two Institutions
SOPHiA GENETICS (NASDAQ: SOPH) today announced that the company has signed a Memorandum of Understanding (MOU) with Memorial Sloan Kettering Cancer Center (MSK) relating to the formation of a joint…
-
6 months ago benzinga.com
Sophia Genetics Affirms FY2026 Sales Guidance of $92.000M-$94.000M vs $93.250M Est
Sophia Genetics (NASDAQ:SOPH) affirms FY2026 sales outlook from $92.000 million-$94.000 million to $92.000 million-$94.000 million vs $93.250 million estimate.
-
6 months ago benzinga.com
Sophia Genetics Q1 EPS $(0.27) Misses $(0.25) Estimate, Sales $21.688M Beat $20.400M Estimate
Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.25) by 8 percent. This is a 3.85 percent decrease over losses of…
-
6 months ago benzinga.com
SOPHiA GENETICS Announces Mount Sinai Health System To Implement Its SOPHiA DDM Platform
SOPHiA GENETICS (NASDAQ:SOPH), a global leader in AI-driven precision medicine, today announced that the Mount Sinai Health System, one of the leading academic health systems in the United States,…
-
6 months ago benzinga.com
BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $8
BTIG analyst Mark Massaro maintains Sophia Genetics (NASDAQ:SOPH) with a Buy and raises the price target from $7 to $8.
8 months ago benzinga.com
Sophia Genetics Q4 Earnings Summary & Key Takeaways
Sophia Genetics Q4 Earnings Summary & Key Takeaways
-
8 months ago benzinga.com
Sophia Genetics Sees FY2026 Sales $92.000M-$94.000M vs $88.000M Est
2026 Financial OutlookBased on information as of today, SOPHiA GENETICS is reaffirming the following guidance:Full-year revenue between $92 million and $94 million, representing approximately 20% to…
-
8 months ago benzinga.com
A Look at Sophia Genetics's Upcoming Earnings Report
A Look at Sophia Genetics's Upcoming Earnings Report
-
8 months ago benzinga.com
SOPHiA GENETICS Adds Two U.S. Healthcare Systems To Its Network To Leverage AI-Native, Cloud-Based SOPHiA DDM To Analyze Complex Genomic Data At Scale
SOPHiA GENETICS (NASDAQ:SOPH), a global leader in AI-driven precision medicine, today announced the addition of two of the largest U.S. healthcare systems to its network.The two new institutions,…
-
9 months ago benzinga.com
Guggenheim Maintains Buy on Sophia Genetics, Raises Price Target to $7
Guggenheim analyst Subbu Nambi maintains Sophia Genetics (NASDAQ:SOPH) with a Buy and raises the price target from $6 to $7.
-
9 months ago benzinga.com
SOPHiA GENETICS Promotes Ross Muken To CEO, Effective July 2026, As Co‑Founder Jurgi Camblong Moves To Executive Chairman Role
Executive Transition PlanSOPHiA GENETICS today announced the promotion of Ross Muken to Chief Executive Officer, effective July 1, 2026. Mr. Muken, who currently serves as President and has been a…
-
9 months ago benzinga.com
SOPHiA GENETICS Expects FY26 Revenue Of $92M-$94M, up ~20%-22% YoY
Full Year 2026 GuidanceBased on information as of today, SOPHiA GENETICS is providing the following FY 2026 guidance:Full year revenue between $92 million and $94 million, representing approximately…
-
9 months ago benzinga.com
SOPHiA GENETICS Reports Preliminary Q4 Revenue Of At Least $21M, Representing Increase Of ~20% YoY; FY25 Preliminary Revenue Of ~77M, Up ~18% YoY
Fourth Quarter 2025 Preliminary Unaudited Financial ResultsRevenue of at least $21 million, representing an increase of approximately 20% year-over-yearPerformed over 105,000 analyses on SOPHiA DDM™…
11 months ago benzinga.com
Zscaler To Rally More Than 9%? Here Are 10 Top Analyst Forecasts For Monday
Zscaler To Rally More Than 9%? Here Are 10 Top Analyst Forecasts For Monday
-
11 months ago benzinga.com
BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $7
BTIG analyst Mark Massaro maintains Sophia Genetics (NASDAQ:SOPH) with a Buy and raises the price target from $6 to $7.
12 months ago benzinga.com
Earnings Scheduled For November 4, 2025
Earnings Scheduled For November 4, 2025
-
1 year ago benzinga.com
SOPHiA GENETICS And A.D.A.M. Innovations Partner To Launch AI-Powered Liquid Biopsy Genomic Testing And Develop Companion Diagnostic For Cancer Care In Japan
- A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS (NASDAQ:SOPH), an AI technology company pioneering data-driven medicine, today announced at ESMO a…
1 year ago benzinga.com
2 Under-The-Radar Health-Tech Stocks With Surging Momentum Scores
Two under-the-radar health-tech stocks are seeing their Momentum scores surge in Benzinga's Edge Stock Rankings.
-
1 year ago benzinga.com
Myriad Genetics And SOPHiA GENETICS Collaborate To Develop And Provide Pharmaceutical Companies With Innovative Global Liquid Biopsy Companion Diagnostic Test
Myriad Genetics (NASDAQ:MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (NASDAQ:SOPH), an AI technology company transforming precision medicine, announced…
-
1 year ago benzinga.com
Sophia Genetics Affirms FY2025 Sales Guidance of $72.000M-$76.000M vs $74.200M Est; Projects Adjusted EBITDA Loss Between $35M-$39M
Sophia Genetics (NASDAQ:SOPH) affirms FY2025 sales outlook from $72.000 million-$76.000 million to $72.000 million-$76.000 million vs $74.200 million estimate.
-
1 year ago benzinga.com
Sophia Genetics Q2 EPS $(0.33) Misses $(0.23) Estimate, Sales $18.323M Beat $17.480M Estimate
Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $(0.23) by 43.48 percent. This is a 43.48 percent decrease over losses of…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
2 years ago benzinga.com
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
-
2 years ago benzinga.com
Heico Posts Upbeat Earnings, Joins Surmodics, Abercrombie & Fitch And Other Big Stocks Moving Higher On Wednesday
Heico Posts Upbeat Earnings, Joins Surmodics, Abercrombie & Fitch And Other Big Stocks Moving Higher On Wednesday
-
2 years ago benzinga.com
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.